Partial Inhibition Of The Key Glycolytic Enzyme Pfkfb3 In Myeloid Cells Impacts Whole-Body Immune Cell And Liver Metabolism, But Not Atherogenesis.
Joost D. de Bruijn, Kim van Kuijk, Mitchell Bijnen, Marion J. Gijbels, Kristiaan Wouters, Peter Carmeliet, Judith C. Sluimer (2019). Partial Inhibition Of The Key Glycolytic Enzyme Pfkfb3 In Myeloid Cells Impacts Whole-Body Immune Cell And Liver Metabolism, But Not Atherogenesis.. , 287, DOI: https://doi.org/10.1016/j.atherosclerosis.2019.06.055.
